{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:21:37Z","timestamp":1760188897414},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s11938-006-0002-y","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T17:14:49Z","timestamp":1180890889000},"page":"456-463","source":"Crossref","is-referenced-by-count":16,"title":["Treatment of osteoporosis in patients with chronic liver disease and in liver transplant recipients"],"prefix":"10.1007","volume":"9","author":[{"given":"Naim M.","family":"Maalouf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khashayar","family":"Sakhaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/00365520310000681a","volume":"38","author":"K Bjoro","year":"2003","unstructured":"Bjoro K, Brandsaeter B, Wiencke K, et al.: Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. Scand J Gastroenterol 2003, 38:320\u2013327.","journal-title":"Scand J Gastroenterol"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gut.31.1.82","volume":"31","author":"T Diamond","year":"1990","unstructured":"Diamond T, Stiel D, Lunzer M, et al.: Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990, 31:82\u201387.","journal-title":"Gut"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00223-001-2028-4","volume":"69","author":"M Ninkovic","year":"2001","unstructured":"Ninkovic M, Love SA, Tom B, et al.: High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 2001, 69:321\u2013326.","journal-title":"Calcif Tissue Int"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00042737-200012080-00013","volume":"12","author":"M Ninkovic","year":"2000","unstructured":"Ninkovic M, Skingle SJ, Bearcroft PW, et al.: Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2000, 12:931\u2013935.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(00)03641-2","volume":"357","author":"G Leidig-Bruckner","year":"2001","unstructured":"Leidig-Bruckner G, Hosch S, Dodidou P, et al.: Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 2001, 357:342\u2013347.","journal-title":"Lancet"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/jhep.2001.22758","volume":"33","author":"A Pares","year":"2001","unstructured":"Pares A, Guanabens N, Alvarez L, et al.: Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis. Hepatology 2001, 33:554\u2013560.","journal-title":"Hepatology"},{"key":"2_CR7","first-page":"746","volume":"9","author":"JE Hay","year":"2005","unstructured":"Hay JE, Guichelaar MM: Evaluation and management of osteoporosis in liver disease. Clin Liver Dis 2005, 9:746\u2013766. Comprehensive and up-to-date review on the pathogenesis and treatment of hepatic osteodystrophy.","journal-title":"Clin Liver Dis"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s002239900205","volume":"60","author":"A Monegal","year":"1997","unstructured":"Monegal A, Navasa M, Guanabens N, et al.: Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997, 60:148\u2013154.","journal-title":"Calcif Tissue Int"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","volume":"95","author":"CH Janes","year":"1995","unstructured":"Janes CH, Dickson ER, Okazaki R, et al.: Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995, 95:2581\u20132586.","journal-title":"J Clin Invest"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.510280315","volume":"28","author":"FJ Gallego-Rojo","year":"1998","unstructured":"Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, et al.: Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998, 28:695\u2013699.","journal-title":"Hepatology"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1210\/jc.2004-1978","volume":"90","author":"NM Maalouf","year":"2005","unstructured":"Maalouf NM, Shane E: Osteoporosis after solid organ transplantation. J Clin Endocrinol Metab 2005, 90:2456\u20132465. [Published erratum appears in J Clin Endocrinol Metab 2005, 90:4118.] Concise review of osteoporosis following solid organ transplantation.","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1359\/jbmr.2003.18.12.2190","volume":"18","author":"MM Guichelaar","year":"2003","unstructured":"Guichelaar MM, Malinchoc M, Sibonga JD, et al.: Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease. J Bone Miner Res 2003, 18:2190\u20132199.","journal-title":"J Bone Miner Res"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/lt.500050507","volume":"5","author":"RB Feller","year":"1999","unstructured":"Feller RB, McDonald JA, Sherbon KJ, et al.: Evidence of continuing bone recovery at a mean of 7 years after liver transplantation. Liver Transpl Surg 1999, 5:407\u2013413.","journal-title":"Liver Transpl Surg"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/jlts.2003.50135","volume":"9","author":"KL Hardinger","year":"2003","unstructured":"Hardinger KL, Ho B, Schnitzler MA, et al.: Serial measurements of bone density at the lumbar spine do not predict fracture risk after liver transplantation. Liver Transpl 2003, 9:857\u2013862.","journal-title":"Liver Transpl"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0735-1097(96)00347-6","volume":"28","author":"RW Braith","year":"1996","unstructured":"Braith RW, Mills RM, Welsch MA, et al.: Resistance exercise training restores bone mineral density in heart transplant recipients. J Am Coll Cardiol 1996, 28:1471\u20131477.","journal-title":"J Am Coll Cardiol"},{"key":"2_CR16","unstructured":"National Institutes of Health, Office of Dietary Supplements. Dietary supplement fact sheet: vitamin D. Available at: http:\/\/ods.od.nih.gov\/factsheets\/vitamind. asp. Accessed June 26, 2006."},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00060793-200202000-00011","volume":"9","author":"MF Holick","year":"2002","unstructured":"Holick MF: Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002, 9:87\u201398.","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jhep.2005.10.010","volume":"44","author":"S Euvrard","year":"2006","unstructured":"Euvrard S, Kanitakis J: Skin cancers after liver transplantation: what to do? J Hepatol 2006, 44:27\u201332.","journal-title":"J Hepatol"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02555147","volume":"43","author":"CY Pak","year":"1988","unstructured":"Pak CY, Avioli LV: Factors affecting absorbability of calcium from calcium salts and food. Calcif Tissue Int 1988, 43:55\u201360.","journal-title":"Calcif Tissue Int"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0270-9139(94)90098-1","volume":"20","author":"M Camisasca","year":"1994","unstructured":"Camisasca M, Crosignani A, Battezzati PM, et al.: Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis. Hepatology 1994, 20:633\u2013637.","journal-title":"Hepatology"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0016-5085(82)80291-6","volume":"83","author":"DS Matloff","year":"1982","unstructured":"Matloff DS, Kaplan MM, Neer RM, et al.: Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology 1982, 83:97\u2013102.","journal-title":"Gastroenterology"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0016-5085(82)80292-8","volume":"83","author":"HF Herlong","year":"1982","unstructured":"Herlong HF, Recker RR, Maddrey WC: Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology 1982, 83:103\u2013108.","journal-title":"Gastroenterology"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.1840040216","volume":"4","author":"SA Mobarhan","year":"1984","unstructured":"Mobarhan SA, Russell RM, Recker RR, et al.: Metabolic bone disease in alcoholic cirrhosis: a comparison of the effect of vitamin D2, 25-hydroxyvitamin D, or supportive treatment. Hepatology 1984, 4:266\u2013273.","journal-title":"Hepatology"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1440-1746.1999.01913.x","volume":"14","author":"S Shiomi","year":"1999","unstructured":"Shiomi S, Masaki K, Habu D, et al.: Calcitriol for bone disease in patients with cirrhosis of the liver. J Gastroenterol Hepatol 1999, 14:547\u2013552.","journal-title":"J Gastroenterol Hepatol"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0041-1345(98)01713-8","volume":"31","author":"R Neuhaus","year":"1999","unstructured":"Neuhaus R, Kubo A, Lohmann R, et al.: Calcitriol in prevention and therapy of osteoporosis after liver transplantation. Transplant Proc 1999, 31:472\u2013473.","journal-title":"Transplant Proc"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00298990","volume":"57","author":"MA Valero","year":"1995","unstructured":"Valero MA, Loinaz C, Larrodera L, et al.: Calcitonin and bisphosphonates treatment in bone loss after liver transplantation. Calcif Tissue Int 1995, 57:15\u201319.","journal-title":"Calcif Tissue Int"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0168-8278(00)00093-3","volume":"34","author":"JE Hay","year":"2001","unstructured":"Hay JE, Malinchoc M, Dickson ER: A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 2001, 34:292\u2013298.","journal-title":"J Hepatol"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 2002, 288:321\u2013333.","journal-title":"JAMA"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2796.2004.01342.x","volume":"256","author":"S Ormarsdottir","year":"2004","unstructured":"Ormarsdottir S, Mallmin H, Naessen T, et al.: An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis. J Int Med 2004, 256:63\u201369.","journal-title":"J Int Med"},{"key":"2_CR30","first-page":"47","volume":"89","author":"JS Crippin","year":"1994","unstructured":"Crippin JS, Jorgensen RA, Dickson ER, et al.: Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 1994, 89:47\u201350.","journal-title":"Am J Gastroenterol"},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-8278(00)00067-2","volume":"34","author":"H Isoniemi","year":"2001","unstructured":"Isoniemi H, Appelberg J, Nilsson CG, et al.: Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study. J Hepatol 2001, 34:299\u2013305.","journal-title":"J Hepatol"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1478-3231.2005.01026.x","volume":"25","author":"C Levy","year":"2005","unstructured":"Levy C, Harnois DM, Angulo P, et al.: Raloxifene improves bone mass in osteopenic women with primary biliary cirrhosis: results of a pilot study. Liver Int 2005, 25:117\u2013121.","journal-title":"Liver Int"},{"key":"2_CR33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-110-6-430","volume":"110","author":"T Diamond","year":"1989","unstructured":"Diamond T, Stiel D, Posen S: Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 1989, 110:430\u2013436.","journal-title":"Ann Intern Med"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","volume":"98","author":"N Guanabens","year":"2003","unstructured":"Guanabens N, Pares A, Ros I, et al.: Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Am J Gastroenterol 2003, 98:2268\u20132274.","journal-title":"Am J Gastroenterol"},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/00365520510023279","volume":"40","author":"J Musialik","year":"2005","unstructured":"Musialik J, Petelenz M, Gonciarz Z: Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis: preliminary results after one year. Scand J Gastroenterol 2005, 40:873\u2013874.","journal-title":"Scand J Gastroenterol"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/lt.20466","volume":"11","author":"G Millonig","year":"2005","unstructured":"Millonig G, Graziadei IW, Eichler D, et al.: Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study. Liver Transpl 2005, 11:960\u2013966.","journal-title":"Liver Transpl"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-144-4-200602210-00005","volume":"144","author":"BA Crawford","year":"2006","unstructured":"Crawford BA, Kam C, Pavlovic J, et al.: Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2006, 144:239\u2013248.","journal-title":"Ann Intern Med"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/S0041-1345(02)03242-6","volume":"34","author":"M Hommann","year":"2002","unstructured":"Hommann M, Abendroth K, Lehmann G, et al.: Effect of transplantation on bone: osteoporosis after liver and multivisceral transplantation. Transplant Proc 2002, 34:2296\u20132298.","journal-title":"Transplant Proc"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1046\/j.1523-1755.2003.00012.x","volume":"63","author":"SL Fan","year":"2003","unstructured":"Fan SL, Kumar S, Cunningham J: Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation. Kidney Int 2003, 63:2275\u20132279.","journal-title":"Kidney Int"},{"key":"2_CR40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0168-8278(92)90066-X","volume":"15","author":"N Guanabens","year":"1992","unstructured":"Guanabens N, Pares A, del Rio L, et al.: Sodium fluoride prevents bone loss in primary biliary cirrhosis. J Hepatol 1992, 15:345\u2013349.","journal-title":"J Hepatol"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, et al.: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001, 344:1434\u20131441.","journal-title":"N Engl J Med"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0002-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-006-0002-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0002-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:48:12Z","timestamp":1587577692000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-006-0002-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s11938-006-0002-y","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}